The long-lasting effect of TU-199, a novel H+,K+-ATPase inhibitor, on gastric acid secretion in dogs

Journal of Pharmacy and Pharmacology

Volumn 51, Issue 4, 1999, Pages 457-464

  Uchiyama, Kazuyuki ^a,b   Wakatsuki, Daisuke ^a   Kakinoki, Bunpei ^a   Takeuchi, Yoshishige ^a   Araki, Tsutomu ^a   Morinaka, Yasuhiro ^a  

^a D Division Tokyo Tanabe Co Ltd   (Japan)

^b Tokyo Tanabe Company Limited   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

5 METHOXY 2 [(4 METHOXY 3,5 DIMETHYLPYRID 2 YL)METHYLSULPHINYL] 1H IMIDAZO[4,5B]PYRIDINE; BENATOPRAZOLE; CARBACHOL; ENZYME INHIBITOR; HISTAMINE; HYDROGEN POTASSIUM ADENOSINE TRIPHOSPHATASE; IMIDAZOPYRIDINE DERIVATIVE; LANSOPRAZOLE; OMEPRAZOLE; TETRAGASTRIN; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; DOG; DOSE RESPONSE; DRUG POTENCY; FEMALE; MALE; MEASUREMENT; MICROSOME; NONHUMAN; ORAL DRUG ADMINISTRATION; STOMACH ACID SECRETION; STOMACH FISTULA; STOMACH MUCOSA; STOMACH PH;

2-PYRIDINYLMETHYLSULFINYLBENZIMIDAZOLES; ANALGESICS, NON-NARCOTIC; ANIMALS; ANTI-ULCER AGENTS; CARBACHOL; DOGS; DOSE-RESPONSE RELATIONSHIP, DRUG; ENZYME INHIBITORS; FEMALE; GASTRIC ACID; GASTRIC FISTULA; GASTRIC MUCOSA; H(+)-K(+)-EXCHANGING ATPASE; HISTAMINE; HYDROGEN-ION CONCENTRATION; IMIDAZOLES; MALE; MICROSOMES; OMEPRAZOLE; PYRIDINES; STOMACH; TETRAGASTRIN; TIME FACTORS;

EID: 0032998705     PISSN: 00223573     EISSN: None     Source Type: Journal    
DOI: 10.1211/0022357991772510     Document Type: Article

References (18)

1. Burget, D. W., Chiverton, S. G., Hunt, R. H. (1990) Is there an optimal degree of acid suppression for healing of duodenal ulcers? A model of the relationship between ulcer healing and acid suppression. Gastroenterology 99: 345-351
2. 2-antagonists. Gastroenterology 88: 1842-1851
3. Fitton, A., Wiseman, L. (1996) Pantoprazole. A review of its pharmacological properties and therapeutic use in acid-related disorders. Drugs 51: 460-482
4. Howden, C. W., Forrest, J. A., Reid, J. L. (1984) Effects of single and repeated doses of omeprazole on gastric acid and pepsin secretion in man. Gut 25: 707-710
5. Krier, C., Bohrer, H., Jurs, G., Warth, S., Just, O. H. (1990) Continuous intragastric pH measurement in intensive care patients treated with ranitidine and tube feeding. Anasth. Intensivther. Notfallmed. 25: 10-13
6. Larsson, H., Carlsson, E., Junggren, U., Olbe, L., Sjostrand, S. E., Skanberg, I., Sundell, G. (1983) Inhibition of gastric acid secretion by omeprazole in the dog and rat. Gastroenterology 85: 900-907
7. Lind, T., Cederberg, C., Ekenved, G., Haglund, U., Olbe, L. (1983) Effect of omeprazole - a gastric proton pump inhibitor - on pentagastrin-stimulated acid secretion in man. Gut 24: 270-276
8. Lowry, O. H., Rosebrough, N. J., Farr, A. L., Randall, R. J. (1951) Protein measurement with the Folin phenol reagent. J. Biol. Chem. 193: 265-275
9. Lui, C. Y., Amidon, G. L., Berardi, R. R., Fleisher, D., Youngberg, C., Dressman, J. B. (1986) Comparison of gastrointestinal pH in dogs and humans: implications on the use of the beagle dog as a model for oral absorption in humans. J. Pharm. Sci. 75: 271-274
10. +)-adenosine triphosphatase by the proton pump inhibitor AG-1749. J. Pharmacol. Exp. Ther. 248: 799-805
11. 2-receptor antagonist famotidine in rats and dogs. Jpn J. Pharmacol. 55: 425-436
12. Postius, S., Brauer, U., Kromer, W. (1991) The novel proton pump inhibitor pantoprazole elevates intragastric pH for a prolonged period when administered under conditions of stimulated gastric acid secretion in the gastric fistula dog. Life Sci. 49: 1047-1052
13. Prakash, A., Faulds, D. (1998) Rabeprazole. Drugs 55: 261-267
14. Reynolds, J. R., Walt, R. P., Hardcastle, J. D., Clark, A. G., Smart, H. L., Langman, M. J. (1986) 24-hour intragastric pH: continuous monitoring or nasogastric aspiration? Digestion 33: 219-224
15. Samloff, I. M. (1989) Peptic ulcer: the many proteinases of aggression. Gastroenterology 96: 586-595
16. Satoh, H., Inatomi, N., Nagaya, H., Inada, I., Nohara, A., Nakamura, N., Maki, Y. (1989) Antisecretory and antiulcer activities of a novel proton pump inhibitor AG-1749 in dogs and rats. J. Pharmacol. Exp. Ther. 248: 806-815
17. Yamamoto, O., Okada, Y., Okabe, S. (1984) Effects of a proton pump inhibitor, omeprazole, on gastric secretion and gastric and duodenal ulcers or erosions in rats. Dig. Dis. Sci. 29: 394-401
18. +)-activated adenosinetriphosphatase from beef brain. Biochem. Biophys. Res. Commun. 40: 880-886